An Add-On Treatment for Moderate COPD with Squill-Oxymel (a Traditional Formulation from Drimia maritima (L.) Stearn): A Pilot Randomized Triple-Blinded Placebo-Controlled Clinical Trial
Open Access
- 30 May 2022
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-8
Abstract
Background. In traditional Persian medicine, Drimia maritima, with the popular name Squill, has been used to alleviate phlegm dyspnea. Squill has also been shown to have anti-inflammatory and anticholinergic properties. The goal of this research was to see how effective and safe Squill-Oxymel was in treating COPD patients. Method. Forty-two COPD patients were examined for eight weeks in two groups. Patients underwent a 6-minute walk test to assess the treatment’s effectiveness at the beginning and conclusion of the intervention. We utilized St. George’s Respiratory Questionnaire (SGRQ) to evaluate the subjective symptoms of patients in order to measure their quality of life. Results. Patients who received Squill-Oxymel showed a statistically significant increase in 6MWT distance ( ). The mean O2 saturation at the end of the 6MWT before the intervention was significantly greater in the placebo group. ( ). In terms of questionnaire variables, there was a significant difference between placebo and Squill-Oxymel groups in the mean presymptom score ( ) and the mean post-symptom score ( ). Conclusions. The findings of this research provide preliminary evidence for the effectiveness and safety of Squill-Oxymel as an add-on therapy in individuals with mild COPD.Keywords
Funding Information
- The Research Department of Tehran University of Medical Sciences (94-02-86-27538)
This publication has 29 references indexed in Scilit:
- Studies on bronchodilator and cardiac stimulant activities of Urginea indicaBangladesh Journal of Pharmacology, 2013
- Maintenance pharmacotherapy of mild and moderate COPD: What is the Evidence?Respiratory Medicine, 2011
- Validity and Specificity of the Persian Version of the Saint George Respiratory QuestionnaireJournal of Asthma, 2011
- β2‐adrenoceptor agonists: current and future directionBritish Journal of Pharmacology, 2011
- Antiasthmatic effect of Nigella sativa in airways of asthmatic patientsPhytomedicine, 2010
- Screening for Cytotoxic and Antimalarial Activities in Desert Plants of the Negev and Bedouin Market Plant ProductsPharmaceutical Biology, 1999
- A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory QuestionnaireAmerican Review of Respiratory Disease, 1992
- Changes in the Proscillaridin A Content During Micropropagation ofUrginea maritimaPlanta Medica, 1990
- Antiviral Activity of Scillarenin, a Plant BufadienolideJapanese Journal of Microbiology, 1974
- Die herzaktiven Substanzen der Meerzwiebel. Scillaren AHelvetica Chimica Acta, 1933